therapeutics

Related pages:

diabetes control and complications trial

CALM study

UK Prospective Diabetes Study

orlistat in obese type II diabetics

HOPE study

MRC / BHF Heart Protection Study

Proactive (PROspective pioglitAzone Clinical Trial In macroVascular Events) study

EMPA - REG trial - empagliflozin in type 2 diabetes patients with high cardiovascular risk (EMPAREG)

CANVAS Program - Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) trial

SUSTAIN-6 - subcutaneous semaglutide and cardiovascular outcomes in type 2 Diabetes

DECLARE - TIMI 58 - dapagliflozin and cardiovascular outcomes in type 2 diabetes

CREDENCE - canagliflozin and renal outcomes in type 2 diabetes (diabetic) and nephropathy

DAPA HF

Diabetes Remission Clinical Trial (DiRECT) using diet in diabetes